877.225.7284 TEST MENU
News Releases
ThyroSeq Hits Target NPV
11/3/2014
As part of its coverage for the 84th Annual Meeting of the American Thyroid Association, MedPage Today attended oral presentations about ThyroSeq v.2 and reported on the exciting promise for the test with a significant negative predictive value (NPV) of 96%.
To read the MedPage Today article, please visit: http://www.medpagetoday.com/MeetingCoverage/ATA/48382.
To learn more about ThyroSeq v.2, please click here.
More Articles...
- hTERC Fluorescence In Situ Hybridization (FISH) Now Offered by CBLPath
- CBLPath Announces Expansion of Cytopathology Department
- CBLPath Launches New Cytogenetics Division
- Agendia and CBLPath Announce Agreement to Assist Physicians in Diagnostic Assessment of Breast Cancer
- CBLPath Announces Partnership with University of Pittsburgh Medical Center's Division of Molecular and Genomic Pathology
- Sihem Khelifa, M.D. Joins CBLPath Breast Pathology Team
- Ciril-Christian Rizk, M.D. Joins CBLPath Physician’s Office Laboratory Program
- CBLPath Dedicated to Enhancement of Head and Neck Pathology Program
- CBLPath to Present at Lab Quality Confab
- BCR/ABL Quantitative RT-PCR Assay Now Offered by CBLPath
- EGFR Gene Mutation Assay Now Offered by CBLPath
- CBLPath to Be Featured at AMP 2012 and in The Journal of Molecular Diagnostics
- CBLPath Bolsters Cancer Management with New NRAS Gene Mutation Analysis Assay
- Ground-breaking Melanoma FISH Panel Now Offered by CBLPath
- CBLPath Receives Approval from New York State Department of Health for XALKORI® Companion Diagnostic
- CBLPath Exhibiting in Booth #902 at USCAP 2012 Annual Meeting
- CBLPath Offers Only FDA-approved BRAF Companion Diagnostic In-house after Approval from New York State Department of Health
- CBLPath Announces Laboratory Contract with Cigna
- CBLPath Honors Its Medical Staff
- CBLPath Offers New FDA Approved, First-of-Kind ALK Molecular Test
- Alfred Fayemi, M.Sc., M.D., Joins CBLPath Team of Pathologists
- CBLPath Exhibiting at CAP ’11 Booth #217 in September
- Community-based Pathologists Adopting Best Practice™ Partnership Program
- CBLPath Exhibiting at the 2011 APMA Annual Scientific Meeting
- CBLPath Receives Approval from New York State Department of Health for KRAS Mutation Analysis PCR Testing
- CBLPath Exhibiting at USCAP 2011 Annual Meeting, Booth #202
- CBLPath Opens New Molecular Diagnostics Lab
- CBLPath and Sonic Healthcare Limited Finalize Acquisition
- CBLPath Announces Validation of Additional FISH Testing
- CBLPath to be Acquired by Sonic Healthcare Limited
Copyright © 2010–2017 CBLPath, Inc. | Careers | Site Map | Privacy Policy | Contact Us | Disclaimer | 877.225.7284